logo

Tocagen Inc (TOCA)



Trade TOCA now with
  Date
  Headline
5/7/2019 4:06:16 PM Tocagen Q1 Loss/share $0.74 Vs. Loss $0.65 Year Ago
2/27/2019 4:09:19 PM Tocagen Q4 Loss/share $0.96 Vs. Loss $0.55 Year Ago
12/12/2018 8:40:37 PM Tocagen Prices Public Offering Of 3 Mln Shares At $10.00/shr
11/29/2018 8:11:44 AM Tocagen, NRG Oncology To Partner On Phase 2/3 Trial Of Toca 511 & Toca FC In Newly Diagnosed Glioblastoma
9/24/2018 8:07:54 AM Tocagen Appoints Mohamed Ladha As VP To Establish Commercial Organization
8/23/2018 8:08:55 AM Tocagen's Toca 5 Pivotal Phase 3 Trial In Patients With Recurrent Brain Cancer Continues Without Modification
7/9/2018 8:12:15 AM Tocagen Closes Announced License Deal With ApolloBio To Develop And Commercialize Toca 511 & Toca FC In Greater China
5/16/2018 1:45:21 PM B. Riley FBR Initiates Tocagen Inc (TOCA) At Buy With 15 Price Target
5/14/2018 8:04:37 AM Tocagen To Present Preclinical Data On Anti-PD-L1 Product Candidate Toca 521 At ASGCT
4/13/2018 2:44:22 AM This Day That Year: Tocagen
3/7/2018 8:09:03 AM Tocagen Receives European Medicines Agency Orphan Medicinal Product Designation For Toca 511 & Toca FC